These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27693756)

  • 21. Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.
    Gaikwad NW; Yang L; Rogan EG; Cavalieri EL
    Free Radic Biol Med; 2009 Jan; 46(2):253-62. PubMed ID: 18996184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LC-MS/MS method for the simultaneous determination of clarithromycin, rifampicin and their main metabolites in horse plasma, epithelial lining fluid and broncho-alveolar cells.
    Oswald S; Peters J; Venner M; Siegmund W
    J Pharm Biomed Anal; 2011 Apr; 55(1):194-201. PubMed ID: 21310577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical synthesis and biological evaluation of a NAD(P)H:quinone oxidoreductase-1 targeted tripartite quinone drug delivery system.
    Volpato M; Abou-Zeid N; Tanner RW; Glassbrook LT; Taylor J; Stratford I; Loadman PM; Jaffar M; Phillips RM
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3122-30. PubMed ID: 18089707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition.
    Zafar KS; Siegel D; Ross D
    Mol Pharmacol; 2006 Sep; 70(3):1079-86. PubMed ID: 16790533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced expression of cytochrome P450 1A and NAD(P)H:quinone oxidoreductase determined at mRNA, protein, and enzyme activity levels in rats exposed to the carcinogenic azo dye 1-phenylazo-2-naphthol (Sudan I).
    Stiborová M; Dračínská H; Martínek V; Svášková D; Hodek P; Milichovský J; Hejduková Ž; Brotánek J; Schmeiser HH; Frei E
    Chem Res Toxicol; 2013 Feb; 26(2):290-9. PubMed ID: 23289503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement for iron for the production of hydroxyl radicals by rat liver quinone reductase.
    Dicker E; Cederbaum AI
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1282-90. PubMed ID: 7690400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
    Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
    Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of reductase activity to quinone toxicity in three kinds of hepatic cells.
    Ishihara Y; Tsuji K; Ishii S; Kashiwagi K; Shimamoto N
    Biol Pharm Bull; 2012; 35(4):634-8. PubMed ID: 22466573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.
    Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y
    Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of Flavoenzyme-Catalyzed Reduction of Tirapazamine Derivatives: Implications for Their Prooxidant Cytotoxicity.
    Nemeikaitė-Čėnienė A; Šarlauskas J; Jonušienė V; Marozienė A; Misevičienė L; Yantsevich AV; Čėnas N
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.
    Bongard RD; Lindemer BJ; Krenz GS; Merker MP
    Free Radic Biol Med; 2009 Jan; 46(1):25-32. PubMed ID: 18848878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.
    Kucera HR; Livingstone M; Moscoso CG; Gaikwad NW
    Free Radic Res; 2013 Dec; 47(12):1016-26. PubMed ID: 24074361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the contribution of NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) to the reduction of vitamin K in wild-type and NQO1-deficient mice.
    Ingram BO; Turbyfill JL; Bledsoe PJ; Jaiswal AK; Stafford DW
    Biochem J; 2013 Nov; 456(1):47-54. PubMed ID: 24015818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ; Colucci MA; Hassani M; Beall HD; Moody CJ
    Org Biomol Chem; 2007 Nov; 5(22):3665-73. PubMed ID: 17971996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
    Haefeli RH; Erb M; Gemperli AC; Robay D; Courdier Fruh I; Anklin C; Dallmann R; Gueven N
    PLoS One; 2011 Mar; 6(3):e17963. PubMed ID: 21483849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
    Qiu XB; Cadenas E
    Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute quantification of NAD(P)H:quinone oxidoreductase 1 in human tumor cell lines and tissues by liquid chromatography-mass spectrometry/mass spectrometry using both isotopic and non-isotopic internal standards.
    Tang Z; Wu M; Li Y; Zheng X; Liu H; Cheng X; Xu L; Wang G; Hao H
    Anal Chim Acta; 2013 Apr; 772():59-67. PubMed ID: 23540248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley rats.
    Begleiter A; Sivananthan K; Curphey TJ; Bird RP
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):566-72. PubMed ID: 12815004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
    Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.